Another Cannabis Company to Enter the U.S. Market (Hint: It’s Not Aurora)

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) investors are still waiting for the company to make a move, and in the meantime, its rivals are jumping ahead.

| More on:
You Should Know This

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

As states in the U.S. continue to legalize recreational marijuana, the opportunity for that market continues to expand. And while Canopy Growth has already made moves to tap into that market, rival Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) has remained idle.

Although Aurora is likely sizing up investment opportunities and it has added some key personnel into the mix to help on that front; we’ve yet to see a big move from the company. There’s been no word of an acquisition or partnership that would have investors believe that it’s going to be taking advantage of the opportunity in the U.S. anytime soon.

One company that has recently made a move is Green Organic Dutchman Holdings Ltd (TSX:TGOD). On Wednesday, the company announced that it was going to enter the U.S. market as both a “co-founding investor and strategic partner” in Califormulations LLC. The newly established company will be based out of Georgia. TGOD says that it “will work with Califormulations to expedite the U.S. launch of TGOD branded organic hemp-based CBD beverages, as local laws and regulations permit.”

The company will work with Symrise Inc, which supplies fragrances and flavouring to customers in a wide variety of industries, including food and beverages. Califormulations won’t be limited to just TGOD’s brands either, as in the release it states that the new company will serve “global branded companies with concept-to-shelf beverage commercialization support including formulation development, technical services, in-house pilot scale production and contract manufacturing co-ordination.”

TGOD is certainly looking to cash in on the beverage hype in the industry, which could be a big opportunity for the company. Getting a footprint in the U.S. market, especially for beverages, will be crucial if the company wants to be one of the big players in the industry. While it might not be a big deal such as what Canopy secured with Constellation Brands, it still gives it a leg up on Aurora, at least for the time being.

With the farm bill in the U.S. making it legal for hemp-derived CBD products, there’s an opening for Canadian companies to now enter the market. And especially with U.S. cannabis companies expanding, we could see competition ramp up significantly.

There’s little time to waste, which makes the lack of movement from a company like Aurora very puzzling. It’s hard to imagine that the company isn’t in talks, but the longer it waits before making a move, the more of a disadvantage it could face — unless Aurora is working on a significant deal with a big beverage company, as rumoured in the past with Coca-Cola.

Bottom line

For TGOD, making a move into the U.S. market is a big one for the company, which will help unlock significant growth opportunities. It also puts pressure on its peers, and Aurora especially might feel that it needs to do something sooner rather than later.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »